Announced Fri, 24 Jul · 19:25 IST
Aarti Drugs board meeting on July 31, 2026 to consider Q1 FY27 audited results
Results View source PDF
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
—1-day move
₹405.15
prior close
₹406.35
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.1+1.2+1.9+1.6——————————
Up moveDown movePending
AI summary
Aarti Drugs has informed BSE that its Board of Directors will meet on Friday, July 31, 2026 to consider, approve and take on record the audited financial results for the quarter ended June 30, 2026. The trading window for dealing in company shares will remain closed until 48 hours after the results are declared.
Likely market impact
Routine compliance intimation. Watch the Q1 FY27 audited results declaration on July 31, 2026 for actual performance insights.